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The high prevalence of both infection with Myco- 
bacterium tuberculosis and active tuberculosis among 
prison inmates .[1-4], the high prevalence of HIV 
infection among inmates 151, and the living conditions 
in prisons, are all conducive to tuberculosis trans- 
mission. Analysis of restriction fragment length poly- 
morphisms (RFLPs) is a well-established method of 
DNA fingerprinting that has been used to trace the 
transmission of particular strains of M. tuberculosis 
during investigations of outbreaks [6-81. This report 
describes the use of RFLP fingerprinting analysis (with 
IS61 10) to trace the transmission of particular strains of 
M.  tuberculosis in a 3-year study (1993-95) among 
prison inmates diagnosed as suffering from tuberculosis. 
O n  January 1995 our laboratory began to routinely 
perform RFLP analysis on all the isolates of M.  
tuberculosis from each new patient diagnosed as having 
tuberculosis, and retrospectively on  all the isolates 
obtained during 1993 and 1994. The RFLP analysis of 
1993 strains revealed a cluster of isolates from three 
patients with identical RFLP patterns and all of them 
were obtained from inmates of Sevilla I1 prison who 
died before 1995. This fact prompted us to study all 
the isolates of M. tuberculosis from the inmates of that 
prison. Fourteen patients included in this report were 
diagnosed as having tuberculosis by the isolation of 
M.  tuberculosis from clinical specimens. All the patients 
had previously been drug users, and all were HIV- 
infected. The clinical and demographic characteristics 
of the patients are summarized in Table 1. Direct 
smears prepared from clinical specimens were stained 
by the Ziehl-Neelsen method. After digestion and 
decontamination by the N-acetyl-L-cysteine-NaOH 
method 191, the specimens were inoculated on to 
Lowenstein-Jensen medium and 12B medium from 
the BACTEC radiometric culture system. The cultures 
were incubated at 35°C and observed for growth for 
an 8-week period. A commercial M. tuberculosis DNA 
probe (Gen-Probe Accuprobe) was used for identi- 
fication of the isolates. 
RFLP fingerprinting was performed as described 
by van Embden et al  16,101 with minor modifications 
[ll]. IS6110 DNA patterns were analyzed by 
Gelcompar software (Windows 3.1 1; Applied Math, 
Kortrijk, Belgium). Patterns were compared by the 
UPGMA (unweighted pair group method using 
arithmetic averages) clustering method using the Dice 
coefficient 1121. Individual fragments from different 
isolates were considered indistinguishable if the size of 
the larger fragment was less than 5% greater than that 
of the smaller fragment 1131. 
Table 1 Epidemiologic and clinical characteristics of 17 persons with tuberculosis in prison Sevilla 11, Seville 1993-95 
Age Site of 
Patient no. (years) disease 
Date/strain Acid-fast 
isolated smear 
Culture 
site 
Drug 
resistance 
1 33 Pulmonary 6/2/1993 +++ Sputum None 
2 37 Pulmonary 26/3/1993 + Sputum None 
3 40 Pulmonary and 16/12/1993 - Sputum None 
Pleural fluid 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15” 
30 
31 
29 
26 
25 
36 
26 
29 
32 
27 
22 
26 
extrapulmonary 
Pulmonary and 
extrapulmonary 
Pulmonary and 
extrapulmonary 
Pulniouary 
Pulmonary 
Pulmonary 
Pulmonary 
Pulmonary 
Pulmonary 
Pulmonary 
Pulmonary and 
extrapulmonary 
Pulmonary 
Extrapulmonary 
30/1 A995 
30/1/1995 
20/1 1/1995h 
2/3/1995 
16/11/1993 
14/5/1994 
27/12/1994 
9/1/1995 
20/1/1995 
3/4/1995 
20/1/1995 
4/11/1995 
16/3/1995 
7/12/1994 
+ 
+++ 
- 
+++ 
- 
- 
+ 
Urine 
Sputum 
Sputum 
Cerebrospinal fluid 
Sputum 
Sputum 
Pleural fluid 
Sputum 
Sputum 
Sputum 
Sputum 
Sputum 
Sputum 
Sputum 
Adenopathy 
Sputum 
Adenopathy 
None 
Isoniazid 
Rifampicin 
None 
None 
None 
None 
None 
None 
None 
None 
None 
None 
None 
1 6a 31 Extrapulmonary - Cerebrospinal fluid None 
‘RFLP analysis not done. hSusceptibility test performed. 
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During the period of the study, 17 patients from 
Sevilla I1 prison were diagnosed as having tuberculosis: 
11 with pulmonary tuberculosis, one with extra- 
pulmonary tuberculosis and five with both conditions. 
Death occurred in six of the 17 patients. Isolates of 
A4. tuberculosis were obtained from 17 patients: four 
in 1993, three in 1994 and 10 in 1995. All but one 
were susceptible to streptoniycin, isoniazid, rifampin, 
ethambutol and pyrazinamide by the radiometric 1% 
proportion method. RFLP analysis could be performed 
on 14 cultures. Unfortunately, one isolate from 1994 
and two from 1995 could not be recovered for further 
analysis. 
Four distinct RFLP patterns were found among 
the 14 M. tuberculosis isolates from the prison inmates 
during 1993-95 (Figure 1). Two clusters were defined. 
The first cluster (cluster A) included five isolates: three 
in 1993 and two in 1995 (patients 1-5). Patient 1, 
diagnosed as having pulmonary tuberculosis with 
numerous acid-fast bacilli in his sputum, was the source 
case. The second cluster (patients 7-13) included seven 
isolates: one in November 1993, two in June and 
December 1994, respectively, three in January 1995 and 
the last in November 1995. Among 165 isolates from 
patients attending our hospital and analyzed by our 
laboratory in that period of time, only three M .  
tuberculosis isolates (two in 1993 and one in 1995) from 
HIV infected non-inmate patients shared identical 
RFLP patterns with those of this second outbreak. 
Surprisingly, two brothers (patients 1 and 12), the first 
diagnosed in 1993 and the second 2 years later, were 
infected by two different strains. In March 1995, 
two strains with RFLP patterns distinct from those 
previously described (patients 6 and 14) were isolated. 
60 70 80 90 100 
We report the persistence of two different strains 
of M.  tuberculosis causing tuberculosis among prison 
inmates for a period of time as long as 3 years. 
Additionally, two new and different strains of A4. 
tuberculosis had been introduced into the prison in 1995. 
We have demonstrated unequivocally the coexistence 
of at least four different strains causing tuberculosis 
among the inmates of Sevilla I1 prison between 1993 
and 1995, and two of them were responsible for two 
clusters. Our  hospital is one of the three where the 
inmate patients could be referred, and more cases may 
have occurred in this facility during the period of the 
study. Unfortunately, no additional information could 
be obtained from the prison authorities. 
The greatest known risk factor that increases the 
likelihood that a person infected with A4. tuberculosis 
will develop active tuberculosis is immunodeficiency, 
especially that caused by co-infection with HIV [1,2]. 
In addition, a recent infection with 144. tuberculosis 
[3,14] contributes to the risk for developing active 
tuberculosis. Both conditions, which were present in 
our population, may have facilitated tuberculosis 
transmission among the inmates. The risk of active 
tuberculosis among HIV-infected persons, who have a 
progressive decline in immunity, may remain high for 
an indefinite period of time or may even increase as the 
immunosuppression progresses; this fact could explain 
the short time period between exposure and develop- 
ment of active disease in most of the cases. Because the 
risk of developing active tuberculosis is greater among 
inmates, it is essential that prison medical staff increase 
their index of suspicion for tuberculosis in inmates with 
respiratory symptoms, and undertake rapid evaluation 
of any suspected cases [2,5,14,15]. It is also essential 
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Figure 1 RFLP patterns of the 14 M .  tuberculosis isolates. Corresponding dendograms are at the left of the panels. The 
position of the bands in each lane is adjusted (normalized) so that the band positions of all the isolates are mutually 
comparable. Two clusters were defined: cluster A (patients 1-5) and cluster B (patients 7-13). 
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that the correctional facilities, which at present have 
inadequate infection control practices and isolation 
facilities to prevent transmission of M.  tuberculosis, fully 
comply with the current guidelines to reduce the risk 
of tuberculosis spread [14,15]. 
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Gingivocrevicular transudate for HIV screening 
Clin Microbiol Infect 1997; 3: 588-590 
The use of saliva as an alternative biological fluid to 
serum in diagnosis or screening of infectious diseases by 
antibody detection has been the main subject of several 
articles in the last few years [l-61. Sahva samples can be 
obtained simply, without specialized personnel, and the 
process is non-traumatic for the patient and economic 
and poses no contamination risks for health workers. 
For these reasons, saliva samples may be of great utility 
in underdeveloped nations, where there is a severe 
shortage of personnel and specialized equipment. Saliva 
is a mixture of the secretions produced by the salivary 
glands and gingival crevicular transudate (GCT). The 
use of GCT, which has a greater concentration of 
immunoglobulins (Ig) of the IgG type than does 
complete saliva [7], seems to improve detection of such 
Ig in the samples [8]. 
An oral device without preservatives (Salivette, 
Starstedt, Leicester, UK) was used to obtain the GCT 
samples. The device is a cylinder of cotton wool con- 
tained in a polystyrene double tube with a snap top 
(price USA $0.20). The cotton wool was placed in the 
lateral gingival fold until the individual could perceive 
that it had become soft because of its absorption of 
GCT. The samples thus obtained were centrifuged at 
4000 g for 15 min, producing a supernatant which was 
